Are you sure you want to leave this community? Leaving the community will revoke any permissions you have been granted in this community.
The tet-off system has been widely used to create transgenic models of neurological disorders including Alzheimer's, Parkinson's, Huntington's, and prion disease. The utility of this system lies in the assumption that the tetracycline transactivator (TTA) acts as an inert control element and does not contribute to phenotypes under study. Here we report that neuronal expression of TTA can affect hippocampal cytoarchitecture and behavior in a strain-dependent manner. While studying neurodegeneration in two tet-off Alzheimer's disease models, we unexpectedly discovered neuronal loss within the dentate gyrus of single transgenic TTA controls. Granule neurons appeared most sensitive to TTA exposure during postnatal development, and doxycycline treatment during this period was neuroprotective. TTA-induced degeneration could be rescued by moving the transgene onto a congenic C57BL/6J background and recurred on reintroduction of either CBA or C3H/He backgrounds. Quantitative trait analysis of B6C3 F2 TTA mice identified a region on Chromosome 14 that contains a major modifier of the neurodegenerative phenotype. Although B6 mice were resistant to degeneration, they were not ideal for cognitive testing. F1 offspring of TTA C57BL/6J and 129X1/SvJ, FVB/NJ, or DBA/1J showed improved spatial learning, but TTA expression caused subtle differences in contextual fear conditioning on two of these backgrounds, indicating that strain and genotype can interact independently under different behavioral settings. All model systems have limitations that should be recognized and mitigated where possible; our findings stress the importance of mapping the effects caused by TTA alone when working with tet-off models.
Pubmed ID: 22855807
Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.
Mus musculus with name B6.Cg-Tg(Camk2a-tTA)1Mmay/DboJ from IMSR.
View all literature mentionsMus musculus with name B6.Cg-Tg(tetO-APPSwInd)107Dbo/Mmjax from MMRRC.
View all literature mentionsMus musculus with name B6.Cg-Tg(tetO-APPSwInd)102Dbo/Mmjax from MMRRC.
View all literature mentionsMus musculus with name B6.Cg-Tg(tetO-APPSwInd)885Dbo/Mmjax from MMRRC.
View all literature mentionsMus musculus with name B6C3F1/J from IMSR.
View all literature mentionsMus musculus with name B6;CBA-Tg(Camk2a-tTA)1Mmay/J from IMSR.
View all literature mentions